MACROPORE PURICEL LIPOPLASTY SYSTEM— 510(k) K042261

Substantially Equivalent

Macropore Biosurgery, Inc.

FDA 510(k) clearance K042261 for MACROPORE PURICEL LIPOPLASTY SYSTEM, Substantially Equivalent on 2004-09-20. Applicant: Macropore Biosurgery, Inc..

Clearance details

Applicant
Macropore Biosurgery, Inc.
Product code
Code QPB
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
San Diego, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.